NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LKQ Corporation
(NASDAQ:LKQ), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), WellCare Health Plans, Inc. (NYSE:WCG), Masimo Corporation (NASDAQ:MASI),
Workday, Inc. (NASDAQ:WDAY), and Potbelly Corporation (NASDAQ:PBPB), including updated fundamental summaries, consolidated fiscal
reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
LKQ DOWNLOAD: http://Fundamental-Markets.com/register/?so=LKQ
PCRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PCRX
WCG DOWNLOAD: http://Fundamental-Markets.com/register/?so=WCG
MASI DOWNLOAD: http://Fundamental-Markets.com/register/?so=MASI
WDAY DOWNLOAD: http://Fundamental-Markets.com/register/?so=WDAY
PBPB DOWNLOAD: http://Fundamental-Markets.com/register/?so=PBPB
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine LKQ
Corporation (NASDAQ:LKQ), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), WellCare Health Plans, Inc. (NYSE:WCG), Masimo Corporation
(NASDAQ:MASI), Workday, Inc. (NASDAQ:WDAY), and Potbelly Corporation (NASDAQ:PBPB) on a fundamental level and outlines the overall
demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and
overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed January 2nd,
2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
LKQ CORPORATION (LKQ) REPORT OVERVIEW
LKQ's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, LKQ reported revenue of $3,122.38MM vs
$2,465.80MM (up 26.63%) and analysts estimated basic earnings per share $0.42 vs $0.40 (up 5.00%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, LKQ reported revenue of $9,736.91MM vs $8,584.03MM (up 13.43%) and analysts estimated
basic earnings per share $1.73 vs $1.51 (up 14.57%). Analysts expect earnings to be released on February 28th, 2019. The report
will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.41. The estimated
EPS forecast for the next fiscal year is $2.52 and is expected to report on February 28th, 2019.
To read the full LKQ Corporation (LKQ) report, download it here: http://Fundamental-Markets.com/register/?so=LKQ
-----------------------------------------
PACIRA PHARMACEUTICALS, INC. (PCRX) REPORT OVERVIEW
Pacira Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Pacira Pharmaceuticals reported revenue
of $83.45MM vs $67.34MM (up 23.93%) and analysts estimated basic earnings per share -$0.02 vs -$0.19. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Pacira Pharmaceuticals reported revenue of $286.63MM vs $276.37MM (up 3.71%) and
analysts estimated basic earnings per share -$1.07 vs -$1.02. Analysts expect earnings to be released on February 27th, 2019. The
report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.18. The
estimated EPS forecast for the next fiscal year is -$0.07 and is expected to report on February 27th, 2019.
To read the full Pacira Pharmaceuticals, Inc. (PCRX) report, download it here: http://Fundamental-Markets.com/register/?so=PCRX
-----------------------------------------
WELLCARE HEALTH PLANS, INC. (WCG) REPORT OVERVIEW
WellCare Health Plans' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, WellCare Health Plans reported revenue
of $5,058.10MM vs $4,402.90MM (up 14.88%) and analysts estimated basic earnings per share $2.74 vs $3.86 (down 29.02%). For the
twelve months ended December 31st, 2017 vs December 31st, 2016, WellCare Health Plans reported revenue of $17,007.20MM vs
$14,237.10MM (up 19.46%) and analysts estimated basic earnings per share $8.40 vs $5.47 (up 53.56%). Analysts expect earnings to be
released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same
quarter last year was $0.32. The estimated EPS forecast for the next fiscal year is $13.41 and is expected to report on February
5th, 2019.
To read the full WellCare Health Plans, Inc. (WCG) report, download it here: http://Fundamental-Markets.com/register/?so=WCG
-----------------------------------------
MASIMO CORPORATION (MASI) REPORT OVERVIEW
Masimo's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Masimo reported revenue of $210.58MM vs
$193.36MM (up 8.91%) and basic earnings per share $1.09 vs $0.69 (up 57.97%). For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Masimo reported revenue of $798.11MM vs $694.63MM (up 14.90%) and analysts estimated basic earnings per share
$2.55 vs $6.07 (down 57.99%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal
period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.72. The estimated EPS forecast for the
next fiscal year is $3.01 and is expected to report on February 26th, 2019.
To read the full Masimo Corporation (MASI) report, download it here: http://Fundamental-Markets.com/register/?so=MASI
-----------------------------------------
WORKDAY, INC. (WDAY) REPORT OVERVIEW
Workday's Recent Financial Performance
For the three months ended October 31st, 2018 vs October 31st, 2017, Workday reported revenue of $743.19MM vs
$555.39MM (up 33.81%) and analysts estimated basic earnings per share -$0.70 vs -$0.41. For the twelve months ended January 31st,
2018 vs January 31st, 2017, Workday reported revenue of $2,143.05MM vs $1,574.44MM (up 36.12%) and analysts estimated basic
earnings per share -$1.55 vs -$1.94. Analysts expect earnings to be released on February 26th, 2019. The report will be for the
fiscal period ending January 31st, 2019. The reported EPS for the same quarter last year was -$0.32. The estimated EPS forecast for
the next fiscal year is -$1.20 and is expected to report on February 26th, 2019.
To read the full Workday, Inc. (WDAY) report, download it here: http://Fundamental-Markets.com/register/?so=WDAY
-----------------------------------------
POTBELLY CORPORATION (PBPB) REPORT OVERVIEW
Potbelly's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Potbelly reported revenue of $107.00MM
vs $106.13MM (up 0.82%) and analysts estimated basic earnings per share -$0.08 vs -$0.01. For the twelve months ended December
31st, 2017 vs December 31st, 2016, Potbelly reported revenue of $428.11MM vs $407.13MM (up 5.15%) and analysts estimated basic
earnings per share -$0.28 vs $0.32. Analysts expect earnings to be released on February 22nd, 2019. The report will be for the
fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for
the next fiscal year is $0.31 and is expected to report on February 22nd, 2019.
To read the full Potbelly Corporation (PBPB) report, download it here: http://Fundamental-Markets.com/register/?so=PBPB
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
